Development of tumor-targeted nanodelivery systems for novel inhibitors of ERCC1/XPF for chemo and radio-sensitization of solid tumors
Development of tumor-targeted nanodelivery systems for novel inhibitors of ERCC1/XPF for chemo and radio-sensitization of solid tumors
开发用于实体瘤化疗和放射增敏的新型 ERCC1/XPF 抑制剂的肿瘤靶向纳米递送系统
批准号：
495239
负责人：
Ahmed Ahmed
金额：
$0.11万
依托单位：
依托单位国家：
加拿大
项目类别：
财政年份：
2023
资助国家：
加拿大
项目状态：
已结题
起止时间：
2023-10-01 至 2024-10-01
关键词：
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Head and neck cancer (HNC) ranks seventh globally, with over 660,000 new cases, 325,000 deaths annually, and an estimated 30% rise by 2030. Nonsurgical treatments for HNC mainly include radiation therapy and platinum-based DNA damaging therapies. However,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文